Metabasis Therapeutics Overview
- Year Founded
-
1997
- Status
-
Acquired/Merged
- Employees
-
52
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$10.9M
Metabasis Therapeutics General Information
Description
Metabasis Therapeutics Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of novel drugs by applying its proprietary technologies, scientific expertise and unique capabilities for targeting the liver and liver pathways. The company's products include: Promacta; Kyprolis.
Contact Information
Corporate Office
- Research & Development
- 9390 Towne Centre Drive
- San Diego, CA 92121
- United States
Corporate Office
- Research & Development
- 9390 Towne Centre Drive
- San Diego, CA 92121
- United States
Metabasis Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Merger/Acquisition | 28-Jan-2010 | $10.9M | Completed | Generating Revenue | ||
| 7. PIPE | 17-Apr-2008 | Completed | Generating Revenue | |||
| 6. IPO | 16-Jun-2004 | Completed | Generating Revenue | |||
| 5. Corporate | 08-Apr-2004 | Completed | Startup | |||
| 4. Later Stage VC (Series E) | 22-Oct-2003 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series D) | 23-Oct-2001 | Completed | Startup | |||
| 2. Later Stage VC (Series C) | 17-Jul-2000 | $17.5M | $23.5M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 17-Dec-1997 | $6.04M | $6.04M | Completed | Startup |
Metabasis Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series E | ||||||||
| Series D | ||||||||
| Series C | ||||||||
| Series B | ||||||||
| Sub Pref | 10,000,000 | $0.001000 | 8% | $1 | $1 | 1x | $1 | 10.37% |
| Series A | 851,939 | $0.001000 | 8% | $7.09 | $7.09 | 1x | $2.01 | 3.11% |
Metabasis Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Metabasis Therapeutics Patents
Metabasis Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2022174261-A | How to reduce thyroid-related side effects | Active | 16-Sep-2016 | ||
| AU-2017327383-A1 | Method of reducing thyroid-associated side effects | Active | 16-Sep-2016 | ||
| AU-2017327383-B2 | Method of reducing thyroid-associated side effects | Active | 16-Sep-2016 | ||
| CA-3037146-A1 | Method of reducing thyroid-associated side effects | Pending | 16-Sep-2016 | ||
| EP-3512523-A1 | Method of reducing thyroid-associated side effects | Pending | 16-Sep-2016 | A61K31/662 |
Metabasis Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Metabasis Therapeutics Former Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| InterWest Partners | Venture Capital | Minority | ||
| MPM BioImpact | Venture Capital | Minority | ||
| Red Abbey Venture Partners | Venture Capital | Minority | ||
| SCALE Aviation | Venture Capital | Minority | ||
| Sankyo (Other Hardware) | Corporation | Minority |
Metabasis Therapeutics Acquisitions (1)
Metabasis Therapeutics’s most recent deal was a Merger/Acquisition with Cengent Therapeutics. The deal was made on 27-Jun-2006.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Cengent Therapeutics | 27-Jun-2006 | Merger/Acquisition | Drug Discovery |
Metabasis Therapeutics FAQs
-
When was Metabasis Therapeutics founded?
Metabasis Therapeutics was founded in 1997.
-
Where is Metabasis Therapeutics headquartered?
Metabasis Therapeutics is headquartered in San Diego, CA.
-
What is the size of Metabasis Therapeutics?
Metabasis Therapeutics has 52 total employees.
-
What industry is Metabasis Therapeutics in?
Metabasis Therapeutics’s primary industry is Drug Discovery.
-
Is Metabasis Therapeutics a private or public company?
Metabasis Therapeutics is a Private company.
-
What is the current valuation of Metabasis Therapeutics?
The current valuation of Metabasis Therapeutics is .
-
What is Metabasis Therapeutics’s current revenue?
The current revenue for Metabasis Therapeutics is .
-
How much funding has Metabasis Therapeutics raised over time?
Metabasis Therapeutics has raised $114M.
-
Who are Metabasis Therapeutics’s investors?
InterWest Partners, MPM BioImpact, Red Abbey Venture Partners, SCALE Aviation, and Sankyo (Other Hardware) have invested in Metabasis Therapeutics.
-
When was Metabasis Therapeutics acquired?
Metabasis Therapeutics was acquired on 28-Jan-2010.
-
Who acquired Metabasis Therapeutics?
Metabasis Therapeutics was acquired by Ligand Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
